Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2012-01-26

Clinical Trial Update: Role of Enhanced External Counterpulsation (EECP) Therapy in Patients With Resistant Hypertension [NA]

View source ↗

Summary

This clinical trial update reports that a study evaluating enhanced external counterpulsation (EECP) therapy for resistant hypertension has been withdrawn. Spon…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Albert Einstein Healthcare Network | Conditions: Hypertension | NA | Status: WITHDRAWN